| GTO ID | GTC2476 |
| Trial ID | NCT04577326 |
| Disease | Malignant Pleural Mesothelioma |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | M28z1XXPD1DNR CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma |
| Year | 2020 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 20-328 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||